Earlier in December 2025, Recursion Pharmaceuticals reported positive Phase 1b/2 TUPELO trial data for REC-4881 in familial adenomatous polyposis, showing rapid and durable reductions in polyp burden ...

Recursion Pharmaceuticals (RXRX) just delivered encouraging Phase 1b/2 TUPELO data for its FAP drug candidate REC-4881, and that clinical update has quickly reshaped how both Wall Street and ...

Recursion Pharmaceuticals Inc (NASDAQ: RXRX) shares moved higher Wednesday after JPMorgan upgraded the stock to Overweight from Neutral and lifted its price target to $11 from $10. What Happened: ...

For many people, the autumn/winter zone between Thanksgiving and Christmas can be one of the bleakest slogs of the year. Can you think of a better way to kick that off than the most doom-laden concert ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. LONDON — In the year-plus since Najat Khan joined the AI-focused drug ...

After a challenging 12 years trying to use AI to create new medicines, cofounder Chris Gibson stepped down as CEO last week. Can R&D chief and new CEO Najat Khan turn it around? In 2014, Recursion ...

Recursion, Roche, and its Genentech subsidiary have unveiled the latest product of their nearly four-year artificial intelligence (AI) drug discovery collaboration, a whole-genome map of specialized ...

Are you mentally prepared for some heavy-ass shit? You better be mentally prepared for some heavy-ass shit if you're going to hit play on this one. The Denver noise-metal power trio Primitive Man will ...

Virginia Beach-based Born Primitive is bringing its patriot-inspired workout apparel to the Hilltop shopping district. The e-commerce clothing brand, co-founded in a garage in 2014 by former Navy SEAL ...